<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p166" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_166{left:35px;bottom:24px;letter-spacing:-0.34px;word-spacing:0.13px;}
#t2_166{left:306px;bottom:30px;}
#t3_166{left:313px;bottom:24px;letter-spacing:0.16px;}
#t4_166{left:346px;bottom:30px;}
#t5_166{left:351px;bottom:24px;letter-spacing:-0.16px;word-spacing:-0.22px;}
#t6_166{left:517px;bottom:30px;}
#t7_166{left:524px;bottom:24px;letter-spacing:-0.28px;word-spacing:-0.09px;}
#t8_166{left:288px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t9_166{left:288px;bottom:829px;letter-spacing:0.27px;word-spacing:-0.69px;}
#ta_166{left:1115px;bottom:27px;letter-spacing:0.23px;}
#tb_166{left:35px;bottom:777px;letter-spacing:0.08px;word-spacing:-0.14px;}
#tc_166{left:35px;bottom:754px;letter-spacing:-0.05px;word-spacing:0.23px;}
#td_166{left:35px;bottom:713px;letter-spacing:-0.05px;word-spacing:0.24px;}
#te_166{left:35px;bottom:690px;letter-spacing:0.18px;word-spacing:0.01px;}
#tf_166{left:35px;bottom:667px;letter-spacing:0.11px;word-spacing:0.07px;}
#tg_166{left:35px;bottom:645px;letter-spacing:0.05px;word-spacing:0.14px;}
#th_166{left:230px;bottom:653px;letter-spacing:-0.01px;}
#ti_166{left:253px;bottom:645px;letter-spacing:0.13px;word-spacing:0.06px;}
#tj_166{left:35px;bottom:622px;letter-spacing:0.09px;word-spacing:0.1px;}
#tk_166{left:35px;bottom:599px;letter-spacing:0.07px;word-spacing:-0.89px;}
#tl_166{left:35px;bottom:575px;}
#tm_166{left:111px;bottom:583px;letter-spacing:-0.01px;}
#tn_166{left:134px;bottom:575px;letter-spacing:0.17px;word-spacing:0.02px;}
#to_166{left:35px;bottom:552px;letter-spacing:0.12px;word-spacing:0.07px;}
#tp_166{left:35px;bottom:512px;letter-spacing:0.06px;word-spacing:0.13px;}
#tq_166{left:35px;bottom:489px;letter-spacing:0.15px;word-spacing:0.03px;}
#tr_166{left:35px;bottom:465px;letter-spacing:0.08px;word-spacing:-1.13px;}
#ts_166{left:35px;bottom:442px;letter-spacing:0.08px;word-spacing:-0.2px;}
#tt_166{left:508px;bottom:450px;letter-spacing:-0.01px;}
#tu_166{left:532px;bottom:442px;letter-spacing:-0.04px;word-spacing:0.22px;}
#tv_166{left:35px;bottom:419px;letter-spacing:0.16px;word-spacing:0.03px;}
#tw_166{left:565px;bottom:426px;letter-spacing:-0.01px;}
#tx_166{left:35px;bottom:396px;letter-spacing:0.14px;word-spacing:0.04px;}
#ty_166{left:35px;bottom:372px;letter-spacing:0.02px;word-spacing:0.16px;}
#tz_166{left:35px;bottom:349px;letter-spacing:0.17px;word-spacing:0.02px;}
#t10_166{left:35px;bottom:326px;letter-spacing:0.06px;word-spacing:0.12px;}
#t11_166{left:35px;bottom:303px;letter-spacing:0.08px;word-spacing:0.1px;}
#t12_166{left:440px;bottom:310px;letter-spacing:-0.01px;}
#t13_166{left:463px;bottom:303px;letter-spacing:0.17px;word-spacing:0.02px;}
#t14_166{left:35px;bottom:280px;letter-spacing:0.05px;word-spacing:0.13px;}
#t15_166{left:35px;bottom:256px;letter-spacing:0.05px;word-spacing:0.13px;}
#t16_166{left:35px;bottom:233px;letter-spacing:0.29px;word-spacing:-0.1px;}
#t17_166{left:314px;bottom:233px;}
#t18_166{left:330px;bottom:233px;letter-spacing:0.23px;word-spacing:-0.05px;}
#t19_166{left:390px;bottom:241px;letter-spacing:-0.01px;}
#t1a_166{left:35px;bottom:193px;letter-spacing:0.14px;word-spacing:0.04px;}
#t1b_166{left:35px;bottom:171px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1c_166{left:35px;bottom:148px;letter-spacing:0.05px;word-spacing:-0.68px;}
#t1d_166{left:35px;bottom:124px;letter-spacing:0.15px;word-spacing:0.04px;}
#t1e_166{left:153px;bottom:132px;letter-spacing:-0.01px;}
#t1f_166{left:176px;bottom:124px;letter-spacing:0.02px;word-spacing:0.16px;}
#t1g_166{left:35px;bottom:101px;letter-spacing:0.15px;word-spacing:0.04px;}
#t1h_166{left:35px;bottom:78px;letter-spacing:0.08px;word-spacing:0.11px;}
#t1i_166{left:532px;bottom:85px;letter-spacing:-0.01px;}
#t1j_166{left:555px;bottom:78px;letter-spacing:0.45px;}
#t1k_166{left:35px;bottom:55px;letter-spacing:0.13px;word-spacing:0.05px;}
#t1l_166{left:618px;bottom:777px;letter-spacing:0.15px;word-spacing:-0.38px;}
#t1m_166{left:618px;bottom:754px;letter-spacing:0.16px;word-spacing:0.02px;}
#t1n_166{left:618px;bottom:731px;letter-spacing:0.05px;word-spacing:0.15px;}
#t1o_166{left:618px;bottom:707px;letter-spacing:0.05px;word-spacing:0.14px;}
#t1p_166{left:765px;bottom:715px;letter-spacing:0.1px;}
#t1q_166{left:810px;bottom:707px;letter-spacing:0.09px;word-spacing:0.1px;}
#t1r_166{left:618px;bottom:684px;letter-spacing:0.11px;word-spacing:0.07px;}
#t1s_166{left:618px;bottom:661px;letter-spacing:0.15px;word-spacing:0.04px;}
#t1t_166{left:618px;bottom:638px;letter-spacing:0.25px;word-spacing:-0.06px;}
#t1u_166{left:948px;bottom:638px;letter-spacing:0.13px;word-spacing:0.05px;}
#t1v_166{left:618px;bottom:614px;letter-spacing:0.17px;word-spacing:-1.21px;}
#t1w_166{left:885px;bottom:614px;letter-spacing:0.12px;word-spacing:0.07px;}
#t1x_166{left:618px;bottom:591px;letter-spacing:0.05px;word-spacing:0.14px;}
#t1y_166{left:618px;bottom:568px;letter-spacing:0.13px;word-spacing:0.05px;}
#t1z_166{left:618px;bottom:545px;letter-spacing:0.09px;word-spacing:0.11px;}
#t20_166{left:618px;bottom:522px;letter-spacing:0.14px;word-spacing:-0.11px;}
#t21_166{left:618px;bottom:498px;letter-spacing:0.09px;word-spacing:0.09px;}
#t22_166{left:618px;bottom:475px;letter-spacing:0.16px;word-spacing:0.03px;}
#t23_166{left:618px;bottom:436px;letter-spacing:0.3px;word-spacing:-0.11px;}
#t24_166{left:618px;bottom:407px;word-spacing:0.18px;}
#t25_166{left:618px;bottom:383px;letter-spacing:0.08px;word-spacing:-0.71px;}
#t26_166{left:618px;bottom:360px;letter-spacing:0.08px;word-spacing:0.11px;}
#t27_166{left:618px;bottom:337px;letter-spacing:-0.02px;}
#t28_166{left:669px;bottom:345px;letter-spacing:0.03px;}
#t29_166{left:777px;bottom:337px;letter-spacing:0.08px;word-spacing:-0.14px;}
#t2a_166{left:618px;bottom:314px;letter-spacing:0.01px;word-spacing:-0.1px;}
#t2b_166{left:618px;bottom:291px;letter-spacing:0.05px;word-spacing:0.14px;}
#t2c_166{left:618px;bottom:267px;letter-spacing:0.03px;word-spacing:0.16px;}
#t2d_166{left:618px;bottom:244px;letter-spacing:0.25px;}
#t2e_166{left:662px;bottom:252px;letter-spacing:0.08px;}
#t2f_166{left:752px;bottom:244px;letter-spacing:-0.07px;word-spacing:0.26px;}
#t2g_166{left:618px;bottom:221px;letter-spacing:0.01px;word-spacing:0.17px;}
#t2h_166{left:618px;bottom:198px;letter-spacing:0.17px;word-spacing:0.02px;}
#t2i_166{left:873px;bottom:205px;letter-spacing:0.11px;}
#t2j_166{left:618px;bottom:159px;letter-spacing:0.05px;word-spacing:-1.1px;}
#t2k_166{left:618px;bottom:135px;letter-spacing:0.02px;word-spacing:-0.73px;}
#t2l_166{left:618px;bottom:112px;letter-spacing:0.09px;word-spacing:-1.02px;}
#t2m_166{left:618px;bottom:89px;letter-spacing:0.22px;word-spacing:-0.03px;}
#t2n_166{left:618px;bottom:66px;letter-spacing:0.12px;word-spacing:0.07px;}
#t2o_166{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_166{font-size:10px;font-family:ArialMT_5tg;color:#000;}
.s1_166{font-size:6px;font-family:ArialMT_5tg;color:#000;}
.s2_166{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_166{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_166{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s5_166{font-size:11px;font-family:ArialMT_5tg;color:#000;}
.s6_166{font-size:17px;font-family:Arial-ItalicMT_kb;color:#000;}
.s7_166{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts166" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-ItalicMT_kb;
	src: url("fonts/Arial-ItalicMT_kb.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg166Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg166" style="-webkit-user-select: none;"><object width="1210" height="935" data="166/166.svg" type="image/svg+xml" id="pdf166" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_166" class="t s0_166">Version 4.2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_166" class="t s1_166">© </span>
<span id="t3_166" class="t s0_166">(NCCN </span>
<span id="t4_166" class="t s1_166">© </span>
<span id="t5_166" class="t s0_166">), All rights reserved. NCCN Guidelines </span>
<span id="t6_166" class="t s1_166">® </span>
<span id="t7_166" class="t s0_166">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_166" class="t s2_166">NCCN Guidelines Version 4.2024 </span>
<span id="t9_166" class="t s2_166">Head and Neck Cancers </span>
<span id="ta_166" class="t s3_166">MS-25 </span>
<span id="tb_166" class="t s4_166">pregabalin (category 2B), or gabapentin for pain related to oral mucositis, </span>
<span id="tc_166" class="t s4_166">as clinically indicated and as tolerated. </span>
<span id="td_166" class="t s4_166">Avasopasem manganese, a superoxide dismutase mimetic that rapidly </span>
<span id="te_166" class="t s4_166">and selectively converts superoxide to hydrogen peroxide and oxygen, </span>
<span id="tf_166" class="t s4_166">has shown potential benefit in protecting normal tissue from radiation </span>
<span id="tg_166" class="t s4_166">therapy-induced damage. </span>
<span id="th_166" class="t s5_166">353 </span>
<span id="ti_166" class="t s4_166">A follow up randomized, placebo controlled </span>
<span id="tj_166" class="t s4_166">phase III trial (ROMAN) demonstrated a 16% relative reduction in severe </span>
<span id="tk_166" class="t s4_166">mucositis incidence and a 56% relative reduction in duration of severe oral </span>
<span id="tl_166" class="t s4_166">mucositis. </span>
<span id="tm_166" class="t s5_166">354 </span>
<span id="tn_166" class="t s4_166">Due to overlapping confidence intervals of the primary </span>
<span id="to_166" class="t s4_166">endpoint, an confirmatory phase III study is underway. </span>
<span id="tp_166" class="t s4_166">NCCN Panel members agree that reactive feeding tube placement, in </span>
<span id="tq_166" class="t s4_166">which patients are first given oral nutrition supplements, followed by </span>
<span id="tr_166" class="t s4_166">enteral feeding, when maintenance of nutritional requirements is no longer </span>
<span id="ts_166" class="t s4_166">possible, is appropriate in selected patients with H&amp;N cancers, </span>
<span id="tt_166" class="t s5_166">321 </span>
<span id="tu_166" class="t s4_166">such as </span>
<span id="tv_166" class="t s4_166">those in which tumors or mucositis interfere with swallowing function. </span>
<span id="tw_166" class="t s5_166">355 </span>
<span id="tx_166" class="t s4_166">Reactive feeding tube placement should be considered if at least two of </span>
<span id="ty_166" class="t s4_166">the following criteria are met: inability to maintain adequate intake (ie, </span>
<span id="tz_166" class="t s4_166">&lt;60% of estimated energy expenditure) for more than 10 days; greater </span>
<span id="t10_166" class="t s4_166">than 5% weight loss in a single month; severe mucositis, odynophagia, </span>
<span id="t11_166" class="t s4_166">dysphagia, or aspiration; or older age (ie, &gt;60 years). </span>
<span id="t12_166" class="t s5_166">356 </span>
<span id="t13_166" class="t s4_166">A retrospective </span>
<span id="t14_166" class="t s4_166">analysis including 100 patients treated with chemoradiation for advanced </span>
<span id="t15_166" class="t s4_166">SCCHN showed that age &gt;60 years was the most significant risk factor </span>
<span id="t16_166" class="t s4_166">predicting need for enteral feeding ( </span><span id="t17_166" class="t s6_166">P </span><span id="t18_166" class="t s4_166">= .003). </span>
<span id="t19_166" class="t s5_166">357 </span>
<span id="t1a_166" class="t s4_166">There is no consensus about whether prophylactic tube placement is </span>
<span id="t1b_166" class="t s4_166">appropriate. Advantages of prophylactic tube placement include </span>
<span id="t1c_166" class="t s4_166">reductions in hospitalizations and treatment-related weight loss, as well as </span>
<span id="t1d_166" class="t s4_166">improved QOL. </span>
<span id="t1e_166" class="t s5_166">358 </span>
<span id="t1f_166" class="t s4_166">However, this practice is also associated with </span>
<span id="t1g_166" class="t s4_166">disadvantages, such as longer dependence on feeding tubes and worse </span>
<span id="t1h_166" class="t s4_166">long-term functional outcomes, compared to a reactive approach. </span>
<span id="t1i_166" class="t s5_166">358 </span>
<span id="t1j_166" class="t s4_166">The </span>
<span id="t1k_166" class="t s4_166">NCCN Guidelines provide recommendations for prophylactic tube </span>
<span id="t1l_166" class="t s4_166">placement, which should be strongly considered in high-risk patients (eg, </span>
<span id="t1m_166" class="t s4_166">those with severe pretreatment weight loss, ongoing dehydration or </span>
<span id="t1n_166" class="t s4_166">dysphagia, significant comorbidities, severe aspiration risk, anticipated </span>
<span id="t1o_166" class="t s4_166">swallowing issues). </span>
<span id="t1p_166" class="t s5_166">321,323 </span>
<span id="t1q_166" class="t s4_166">In patients with adequate swallowing function, </span>
<span id="t1r_166" class="t s4_166">care must be given with the help of speech and language pathologists to </span>
<span id="t1s_166" class="t s4_166">ensure that patients continue to swallow to prevent severe fibrosis and </span>
<span id="t1t_166" class="t s4_166">permanent feeding tube dependence (see </span><span id="t1u_166" class="t s6_166">Principles of Nutrition: </span>
<span id="t1v_166" class="t s6_166">Management and Supportive Care </span><span id="t1w_166" class="t s4_166">in the NCCN Guidelines for Head and </span>
<span id="t1x_166" class="t s4_166">Neck Cancers). With swallowing therapy, adequate pain control, and </span>
<span id="t1y_166" class="t s4_166">access to IV fluids, feeding tubes can be avoided in most patients. The </span>
<span id="t1z_166" class="t s4_166">NCCN Guidelines do not recommend prophylactic tube placement in </span>
<span id="t20_166" class="t s4_166">lower-risk patients (ie, those without significant pretreatment weight loss, </span>
<span id="t21_166" class="t s4_166">significant aspiration, or severe dysphagia), although these patients’ </span>
<span id="t22_166" class="t s4_166">weights should be carefully monitored during and after treatment. </span>
<span id="t23_166" class="t s3_166">Oral/Dental Evaluation and Management </span>
<span id="t24_166" class="t s4_166">Patients with H&amp;N cancers are at risk of oral and dental complications </span>
<span id="t25_166" class="t s4_166">after surgery or RT because of treatment-induced xerostomia and salivary </span>
<span id="t26_166" class="t s4_166">gland dysfunction, which are associated with increased dental </span>
<span id="t27_166" class="t s4_166">caries. </span>
<span id="t28_166" class="t s5_166">333,337,341,359-363 </span>
<span id="t29_166" class="t s4_166">In addition, RT to the salivary and oral soft tissues is </span>
<span id="t2a_166" class="t s4_166">also associated with bone demineralization and trismus of the masticatory </span>
<span id="t2b_166" class="t s4_166">muscles. Using IMRT and limiting the RT dose to the salivary glands and </span>
<span id="t2c_166" class="t s4_166">oral cavity have been shown to decrease xerostomia and damage to the </span>
<span id="t2d_166" class="t s4_166">teeth. </span>
<span id="t2e_166" class="t s5_166">359,360,364-370 </span>
<span id="t2f_166" class="t s4_166">Dental/oral evaluation and management can help </span>
<span id="t2g_166" class="t s4_166">decrease dental caries and associated problems such as dentoalveolar </span>
<span id="t2h_166" class="t s4_166">infection and osteoradionecrosis. </span>
<span id="t2i_166" class="t s5_166">337,341,363,364,370-379 </span>
<span id="t2j_166" class="t s4_166">The recommended dental/oral evaluations before, during, and after RT are </span>
<span id="t2k_166" class="t s4_166">described in detail in the algorithm and are summarized here. A dental/oral </span>
<span id="t2l_166" class="t s4_166">treatment plan needs to be implemented before RT and should include the </span>
<span id="t2m_166" class="t s4_166">following: 1) eliminating potential sources of infection; 2) if performing </span>
<span id="t2n_166" class="t s4_166">dental extractions, allowing adequate time for healing before RT; 3) </span>
<span id="t2o_166" class="t s7_166">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
